Good MorningThe equities markets made a small rebound on Wednesday but traders and investors shouldn’t read too much into the move. The S&P 500 gained about 0.75% at the high of the day while trading in a tight range near the low of the previous session. This is an indication of inherent market weakness and one that could lead to a much deeper decline for the market. If the S&P 500 continues to move lower and falls below the 4,300 level the market could take it down another 200 points or more.
The biggest risk this week is the PCE price index on Friday. If the index is hotter than the consensus figure, and there is every reason to think it will be, the onset of tapering at the next FOMC meeting is all but assured. Worse, for the stock market at least, is the fact tighter policy and interest rate hikes will soon follow.
Featured: Elon’s big $266,000 per second purchase (Ad) 
|
Medical | |
Historically, the volume of insider selling tends to exceed that of insider buying. This is partly because when corporate executives and board members exercise granted stock options it is considered a sale activity. Then there are situations when insiders sell stock to diversify their personal por... Read the Full Story |
|
From Our Partners | | Bill Poulos is offering his Smart Trade Options Checklist at no cost today - normally priced at $29.97.
It's a single-page, seven-point filter designed to help traders identify weak setups before placing any options trade. Print it, keep it at your desk, and run it before every trade. The download link expires soon. | | Download your free copy of the Smart Trade Options Checklist now |
|
Markets | |
You may not exactly talk about it outright, but do you have a sneaking suspicion that someone you care about hasn't made great strides in saving for retirement? In fact, the person you love might be grossly behind in saving for one of life's key financial must-dos.
You've got good reason for your... Read the Full Story |
|
Technology | | Cloud-based project management software Asana (NYSE: ASAN) celebrates one year as a public company on September 30. Since making its debut, priced at $21, shares are up more than 400%.
The stock tumbled along with the broader market Tuesday, dropping 10.30% to close at $102.25. Trading volume was 1... Read the Full Story |
|
From Our Partners | | Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.
The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move. | | Watch the documentary briefing and find out which side you land on |
|
Construction | |
Perfect Positioning Is A Two-Edged Sword For Worthington
Worthington (NYSE: WOR) is perfectly positioned for the post-pandemic world. The company makes value-added steel products for manufacturing industries of all varieties, as well as consumer goods and materials for the construction industry. ... Read the Full Story |
|
Markets | |
Cintas Recovers Its Pre-COVID Revenue Levels
We can nit-pick the labor data all day long but one thing is clear in Cintas (NASDAQ: CTAS) Q1 results. Employment levels if not conditions have regained their pre-COVID levels. This is evident not only in the revenue but in the earnings and the outlo... Read the Full Story |
|
From Our Partners | | Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now.
Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen.
Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch. | | Watch how to access the legal backdoor before it closes. |
|
Business Services | | All-in-one video software solution Vimeo (NASDAQ: VMEO) stock is attempting to bottom out after being spun off from parent InterActiveCorp (NASDAQ: IAC). The Company was spun off from its parent in May 2021 and shares have since fallen sharply from a high of $57.88 to a low of $29.31. The company fo... Read the Full Story |
|
Technology | | IPO investing is without a doubt one of the most intriguing opportunities to pursue in the market. Choosing wisely can lead investors towards picking up shares of the next huge winner at low prices while taking a big position in a new public company that fails to find its footing will have investors... Read the Full Story |
|
Markets | | Electronic vehicle (EV) charging network Volta (NASDAQ: VLTA) stock surged after completing its reverse merger with Tortoise Acquisition Corp. II on Aug. 25, 2021. Shares initially sold off after the business combination starting trading under the new symbol as most special purpose acquisition compa... Read the Full Story |
|
Retail/Wholesale | |
There are not many things that are more disheartening to an investor than seeing the value of a particular holding move down sharply. And it can be even more concerning when downward price action coincides with a downgrade from the analyst community.
However, just as an analyst upgrade is not a... Read the Full Story |
|
Basic Materials | |
Cal-Maine’s Dividend Outlook Brightens
We weren't expecting great results from Cal-Maine (NASDAQ: CALM) in the calendar third quarter, fiscal first, and we were partly right. The company posted a loss as expected but it was much less than forecast which is good news for those expecting a di... Read the Full Story |
|
The Early Bird Stock Of The Day Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. | | View Today's Stock Pick |
|
